Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bradley buys Quintiles' Bioglan Pharmaceuticals for $183mm

Executive Summary

Bradley Pharmaceuticals] (brand-name prescription and OTC products in the areas of dermatology, nutrition, and gastroenterology) is acquiring the assets of dermatology company Bioglan Pharmaceuticals, a subsidiary of CRO Quintiles Transnational, for $183mm in cash.
Deal Industry
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Includes Contract
UsernamePublicRestriction

Register